NCT04372927 - ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 10, 2021

Primary Completion Date

April 23, 2022

Study Completion Date

April 23, 2022

Conditions

Locally Advanced Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8

Interventions

DRUG

Cisplatin

Given IV

BIOLOGICAL

Durvalumab

Given IV

DRUG

Etoposide

Given IV

RADIATION

Hypofractionated Radiation Therapy

Undergo hypofractionated radiation therapy

DRUG

Pemetrexed

Given IV

Trial Locations (1)

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle